Project Grant R56DK144181
Award Date 8/1/26
Completion Date 7/31/28
Dollars Obligated $295K
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Gainesville, FL 32611, USA
Similar Awards
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Florida $735,969 on August 10, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop and test microgels for localized immune control in beta cell replacement therapy for type 1 diabetes. The work combines cell and biomaterials engineering to create stem cell-derived beta cells functionalized with negative regulators of immunity—specifically...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Florida $153,500 on May 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to assess thymic output in the context of genetics, environmental exposures, and progression to type 1 diabetes. The research examines how thymic function is impacted during progression to type 1 diabetes, addressing a gap in current understanding of early initiating events that...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Florida $754,682 on May 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate beta cell dysfunction in type 1 diabetes through glucose metabolism studies in human pancreatic tissue. The research addresses mechanisms of beta cell failure by examining glucose sensing and insulin secretory pathway components altered during type 1 diabetes...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Miami $2,962,847 on September 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to dissect the cellular dynamics and mechanisms of human pancreatic beta-cell regeneration using a novel in vivo model. The recipient will leverage an innovative transplantation system in which human pancreatic tissue slices and progenitor cells are engrafted into the...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded $178,000 to Beckman Research Institute of The City of Hope on May 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate how the native pancreatic microenvironment regulates human islet cell function in health and type 1 diabetes. The research employs human pancreatic tissue slices to preserve native cellular architecture and directly compares hormone...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), an institute of the Department of Health and Human Services National Institutes of Health, awarded $795,620 to the University of Massachusetts Medical School on July 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds development and validation of gene-editing technologies to engineer stem cell-derived islets for type 1 diabetes treatment. The research...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded a $802,595 cooperative agreement to Pacific Northwest National Laboratory, a division of Battelle Memorial Institute, on May 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The recipient will conduct spatial multi-omics profiling of human pancreatic islet microenvironments to discover pathways and molecular mediators of early Type 1 Diabetes pathogenesis. The...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Benaroya Research Institute at Virginia Mason $302,000 on July 1, 2026, to develop a vascularized three-dimensional biomimetic microphysiological system (MPS) for isogenic modeling of immune-beta cell interactions in Type 1 Diabetes research. The recipient will adapt a proven perfusion-capable microfluidic skin-on-chip platform—a plexiglass-based chamber system with an open well, microchannel network, and inlet and...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The University of Texas Southwestern Medical Center $799,693 on June 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847, Project Grant R01DK147004). The recipient will develop bioengineered pancreatic islet beta cells as a replacement therapy for Type 1 Diabetes. The research optimizes immune-checkpoint-engineered beta cells designed to induce long-term transplant...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Vanderbilt University Medical Center $175,000 on May 20, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct spatial profiling of pancreatic N-glycosylation in type 1 diabetes. The research employs state-of-the-art imaging technologies to map how protein N-glycosylation—the enzymatic attachment of complex carbohydrate chains to asparagine residues on...